Ter Arkh. 2011;83(10):22-7.
To study levels of hepsidine (Hp), hypoxia-inducible factor-1alpha (HIF-1alpha), erythropoietin (EP) and ferritin in patients with acute leukemia (AL), effects of protein fractions of homogenate of blastic cells (BC) on regulatory proteins studied.
Depending on leukocyte count in the onset of AL, 70 patients with first ever diagnosed AL were divided into two groups: group 1 - 17 patients with leukocyte count > 30 x 10(9)/l, group 2 - 53 patients with leukocyte count < 30 x 10(9)/l. Serum and leukocyte parameters were studied before treatment, during the treatment with cytostatic drugs, in the course of myelotoxic agranulocytosis (MTA), after normalization of hemograms. EP was detected with enzyme immunoassay, serum and leukocyte ferritin - with radioimmunoassay; HIF-1alpha, Hp - sandwich enzyme immunoassay using monospecific antisera and monoclonal antibodies against relevant antigens. Leukocytes were isolated in ficol and verografin solutions density gradient. Chromatographic division of the protein fractions in 3 patients with leukocytosis in AL onset and leukocytes of 3 donors was made by the method of preparative isoelectrofocusing of BC and leukocytes on LKB colon (Sweden). Effects of these fractions were studied on 11 plasma samples from hematological patients and 4 plasma samples from patients with normal hemopoiesis.
Leukocytosis patients with initial AL have serum ferritin, Hp and HIF-1alpha levels about 2-5 times lower than patients without leukocytosis. Cytostatic treatment raises an HIF-1alpha level in BC about 15-fold (85.8 +/- 24.5 pg/ml), in the study group - 3-fold (15.2 +/- 3.3 pg/ml). The highest EP levels were seen in MTA. It is detected that protein fractions isolated from leukocytes of patients with leukocytosis in the disease onset raise HIF-1alpha content irrespective of HIF-1alpha presence in the fraction. Patients free of hematological diseases have no changes of the above proteins.
Great difficulties exist in ferritin and Hp levels between AL patients with leukocytosis in the onset of the disease and without of leukocytosis. The study of leukocytes suggests that tumor cells of such patients contain compounds which can regulate production of HIF-1alpha, Hp and ferritin.
研究急性白血病(AL)患者血清中铁调素(Hp)、缺氧诱导因子-1α(HIF-1α)、促红细胞生成素(EP)和铁蛋白水平,以及原始细胞(BC)匀浆蛋白组分对所研究的调节蛋白的影响。
根据急性白血病发病时的白细胞计数,将70例首次诊断为急性白血病的患者分为两组:第1组-17例白细胞计数>30×10⁹/L的患者,第2组-53例白细胞计数<30×10⁹/L的患者。在治疗前、使用细胞毒性药物治疗期间、骨髓毒性粒细胞缺乏症(MTA)过程中以及血常规恢复正常后,研究血清和白细胞参数。采用酶免疫法检测EP,采用放射免疫法检测血清和白细胞铁蛋白;采用针对相关抗原的单特异性抗血清和单克隆抗体的夹心酶免疫法检测HIF-1α、Hp。在菲可和维诺格拉芬溶液密度梯度中分离白细胞。采用BC和白细胞在LKB柱(瑞典)上的制备性等电聚焦方法,对3例急性白血病发病时白细胞增多患者和3例供者的白细胞进行蛋白质组分的色谱分离。研究这些组分对11例血液系统疾病患者和4例造血正常患者的血浆样本的影响。
初发急性白血病白细胞增多患者的血清铁蛋白、Hp和HIF-1α水平比无白细胞增多患者低约2-5倍。细胞毒性治疗使BC中的HIF-1α水平升高约15倍(85.8±24.5 pg/ml),在研究组中升高3倍(15.2±3.3 pg/ml)。促红细胞生成素水平在骨髓毒性粒细胞缺乏症时最高。研究发现,疾病发病时白细胞增多患者白细胞中分离出的蛋白质组分可提高HIF-1α含量,而与该组分中是否存在HIF-1α无关。无血液系统疾病的患者上述蛋白质无变化。
疾病发病时白细胞增多和无白细胞增多的急性白血病患者在铁蛋白和Hp水平上存在很大差异。对白细胞的研究表明,这类患者的肿瘤细胞含有可调节HIF-!α、Hp和铁蛋白产生的化合物。